|
TMEM165 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.811400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.114760E-01 |
| Normal-vs-Stage2 |
5.480600E-01 |
| Normal-vs-Stage3 |
5.786200E-01 |
| Normal-vs-Stage4 |
5.691800E-01 |
| Stage1-vs-Stage2 |
8.047900E-02 |
| Stage1-vs-Stage3 |
7.132300E-02 |
| Stage1-vs-Stage4 |
1.391620E-01 |
| Stage2-vs-Stage3 |
8.507600E-01 |
| Stage2-vs-Stage4 |
9.081400E-01 |
| Stage3-vs-Stage4 |
7.639800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.498800E-01 |
| Normal-vs-AfricanAmerican |
9.346600E-01 |
| Normal-vs-Asian |
2.150400E-01 |
| Caucasian-vs-AfricanAmerican |
4.046400E-01 |
| Caucasian-vs-Asian |
5.425000E-01 |
| AfricanAmerican-vs-Asian |
4.041000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.427030E-01 |
| Normal-vs-Female |
1.313040E-01 |
| Male-vs-Female |
1.157470E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.622600E-01 |
| Normal-vs-Extreme_Weight |
4.141800E-01 |
| Normal-vs-Obese |
7.065200E-01 |
| Normal-vs-Extreme_Obese |
1.331150E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.332400E-01 |
| Normal_Weight-vs-Obese |
7.002000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.770000E-01 |
| Extreme_Weight-vs-Obese |
5.953400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.144200E-01 |
| Obese-vs-Extreme_Obese |
3.106400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.040800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.391400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.538250E-01 |
| Normal-vs-Age(81-100Yrs) |
1.023020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.642800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.430160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.643820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.138100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.242370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.174000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.655200E-01 |
| Normal-VS-Type2 PRCC |
6.620100E-02 |
| Normal-VS-KIRP CIMP |
1.607400E-01 |
| Normal-VS-Unclassified PRCC |
4.608800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.541200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.090300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.159900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.617900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.099600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.465430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.510400E-01 |
| Normal-vs-N1 |
5.988800E-01 |
| Normal-vs-N2 |
6.539000E-01 |
| N0-vs-N1 |
1.773150E-01 |
| N0-vs-N2 |
4.527800E-01 |
| N1-vs-N2 |
9.046000E-01 |
|
|
